"This center offers dermatology and eye care services"

During the past decade, University of Utah MidValley Dermatology conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 10 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 10 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Utah MidValley Dermatology" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Palvella Therapeutics, Inc." with 4 trials sponsored, "University of Utah" with 4 trials sponsored, "PellePharm, Inc." with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Utah MidValley Dermatology" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator and "Dermira, Inc." with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "University of Utah MidValley Dermatology" are "Atopic Dermatitis" (5 trials), "Psoriasis" (5 trials), "Alopecia Areata" (3 trials), "Pachyonychia Congenita" (3 trials) and "Basal Cell Nevus Syndrome" (2 trials). Many other conditions were trialed in "University of Utah MidValley Dermatology" in a lesser frequency.

Most popular intervention types in "University of Utah MidValley Dermatology" are "Drug" (24 trials), "Other" (3 trials), "Biological" (2 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Baricitinib" (3 trials), "PTX-022" (3 trials), "Patidegib Topical Gel, 2%" (3 trials) and "Lebrikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Utah MidValley Dermatology" are 30 trials for "All" genders.

Currently, there are NaN active trials in "University of Utah MidValley Dermatology". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in University of Utah MidValley Dermatology, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University of Utah MidValley Dermatology, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".